COVID-19 pandemic stress and cancer symptom burden
- PMID: 37541779
- DOI: 10.1136/spcare-2023-004319
COVID-19 pandemic stress and cancer symptom burden
Abstract
Objectives: In a sample of patients with cancer (n=1145) who were assessed during the height of the COVID-19 pandemic, latent profile analysis was used to identify subgroups of patients with distinct stress profiles and to evaluate for differences in demographic and clinical characteristics and symptom severity scores among these subgroups.
Methods: Patients completed measures of cancer-specific and COVID-19 stress, global stress, social isolation, loneliness, depression, state and trait anxiety, morning and evening fatigue, morning and evening energy, sleep disturbance, cognitive function, and pain. Latent profile analysis was used to identify subgroups of patients with distinct stress profiles. Differences among the subgroups in study measures were evaluated using parametric and non-parametric tests.
Results: Using clinically meaningful cut-off scores for the stress measures, four distinct stress profiles were identified (ie, none class (51.3%); low stress and moderate loneliness class (24.4%), high stress and moderate loneliness class (14.0%), and very high stress and moderately high loneliness class (high, 10.3%)). Risk factors associated with membership in the high class included: younger age, lower annual household income, lower functional status and higher comorbidity burden. The two worst stress profiles reported clinically meaningful levels of all of the common symptoms associated with cancer and its treatments.
Conclusion: Findings from this study, obtained prior to the availability of COVID-19 vaccines and anti-viral medications, provide important 'benchmark data' to evaluate for changes in stress and symptom burden in patients with cancer in the postvaccine era and in patients with long COVID-19.
Keywords: Cancer; Chronic conditions; Psychological care.
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.Oncol Nurs Forum. 2023 Aug 17;50(5):647-664. doi: 10.1188/23.ONF.647-664. Oncol Nurs Forum. 2023. PMID: 37677766
-
Distinct Co-occurring Morning and Evening Fatigue Profiles in Patients With Gastrointestinal Cancers Receiving Chemotherapy.Cancer Nurs. 2024 Jan-Feb 01;47(1):E28-E37. doi: 10.1097/NCC.0000000000001148. Epub 2022 Dec 11. Cancer Nurs. 2024. PMID: 36076314 Free PMC article.
-
Worst Pain Severity Profiles of Oncology Patients Are Associated With Significant Stress and Multiple Co-Occurring Symptoms.J Pain. 2022 Jan;23(1):74-88. doi: 10.1016/j.jpain.2021.07.001. Epub 2021 Jul 21. J Pain. 2022. PMID: 34298161 Free PMC article.
-
Distinct Wound Healing and Quality-of-Life Outcomes in Subgroups of Patients With Venous Leg Ulcers With Different Symptom Cluster Experiences.J Pain Symptom Manage. 2017 May;53(5):871-879. doi: 10.1016/j.jpainsymman.2016.12.336. Epub 2017 Jan 4. J Pain Symptom Manage. 2017. PMID: 28063868 Review.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical